title: Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?
authors: Department of Medical Oncology, Guy's Hospital, London, UK.
authors: Alejo
authors: A
authors: Rodriguez-Vida
authors: Noan-Minh
authors: NM
authors: Chau
authors: Simon
authors: S
authors: Chowdhury
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D000068338:Everolimus; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011014:Pneumonia / Q000139:chemically induced*; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; C401859:temsirolimus; D000068338:Everolimus; D020123:Sirolimus